MetLife Investment Management’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

MetLife Investment Management’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,573	Closed	-$120K	–	2783
2021 Q4	$120K	Hold	8,573	–	–	﹤0.01%	2341
2021 Q3	$222K	Hold	8,573	–	–	﹤0.01%	2024
2021 Q2	$392K	Hold	8,573	–	–	﹤0.01%	1723
2021 Q1	$377K	Buy	8,573 +2,959	+53%	+$144K	﹤0.01%	1685
2020 Q4	$173K	Hold	5,614	–	–	﹤0.01%	2055
2020 Q3	$179K	Buy	+5,614	New	+$138K	﹤0.01%	1925

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MetLife Investment Management's AMTI Position: Q1 2022 in Review

MetLife Investment Management sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2022, closing a stake of 8,573 shares — an estimated $120K sold.

MetLife Investment Management first reported a position in AMTI in Q3 2020 and held it in 6 quarters. The position peaked at $392K in Q2 2021. 77 funds tracked by Wall St. Rank hold AMTI as of Q1 2022.

MetLife Investment Management reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
MetLife Investment Management sold 8,573 Applied Molecular Transport Inc. Common Stock shares in Q1 2022, an estimated $120K.
MetLife Investment Management first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 6 quarters.
MetLife Investment Management's Applied Molecular Transport Inc. Common Stock position peaked at $392K in Q2 2021.
77 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.